PREVENTION OF GRAFT FAILURE BY DIETARY N 3 FATTY ACIDS
$293,069M01FY2002RRNIH
Emory University, Atlanta GA
Investigators
Linked publications & trials
Paper 39493420Paper 38633777Paper 38574700Paper 38252758Paper 38195980Paper 37717845Paper 37491672Paper 36651624Paper 35917919Paper 35758529Paper 35307575Paper 35131442Paper 35005320Paper 34907666Paper 34865854Paper 34401721Paper 34352557Paper 34091237Paper 33526782Paper 33478957Paper 33305291Paper 33288872Paper 33230203Paper 32807060Paper 32634120Paper 32446491Paper 32221144Paper 32111975Paper 32056779Paper 32024598Paper 31874800Paper 31857689Paper 31691959Paper 31532792Paper 31427096Paper 31306866Paper 31185252Paper 31171572Paper 31088850Paper 30922668Paper 30855313Paper 30764648Paper 30753254Paper 30737489Paper 30631138Paper 30591038Paper 30124316Paper 30101556Paper 29920418Paper 29872859Paper 29854969Paper 29807322Paper 29564978Paper 29306690Paper 29306517Paper 29290310Paper 29241359Paper 29217296Paper 29203126Paper 29118087Paper 29082582Paper 29040104Paper 29027660Paper 28958901Paper 28944312Paper 28904075Paper 28825494Paper 28660256Paper 28647272Paper 28595089Paper 28532709Paper 28489609Paper 28482209Paper 28460625Paper 28335624Paper 28335622Paper 28283553Paper 28280039Paper 28199816Paper 28158800Paper 28121636Paper 28117927Paper 28027795Paper 27993381Paper 27959335Paper 27955697Paper 27779124Paper 27756851Paper 27622844Paper 27573938Paper 27518177Paper 27493807Paper 27484667Paper 27455401Paper 27423510Paper 27411977Paper 27219346Paper 27176681Paper 27174641Paper 27074126
Abstract
This goal of this study is to determine the dose of eicosapentanoic acid (n-3 Fas) that reduce the rate of platelet depositin at the venous anastomosis and along the whole of a synthetic PTFE dialysis arteriovenous graft. The study will further evaluate the effects of dietary n-3Fas on AVG failure in a randomized, blinded, controlled clinical trial.
View original record on NIH RePORTER →